Recent developments in antifungal susceptibility testing
- 1 June 1991
- journal article
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 13 (11) , 81-85
- https://doi.org/10.1016/0196-4399(91)90038-w
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosisAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatumAntimicrobial Agents and Chemotherapy, 1990
- In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacyAntimicrobial Agents and Chemotherapy, 1989
- New antifungal agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Testing of organisms for susceptibility to triazoles: Is it justified?European Journal of Clinical Microbiology & Infectious Diseases, 1989
- In vitro and in vivo evaluation of antifungal agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- In Vitro Antifungal Susceptibility Testing and Measurement of Levels of Antifungal Agents in Body FluidsClinical Infectious Diseases, 1987
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis ModelThe Journal of Infectious Diseases, 1983
- Factors Influencing the Susceptibility of Candida albicans to the Polyenoic Antibiotics Nystatin and Amphotericin BJournal of General Microbiology, 1978